Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Case Report Volume 9 Issue 7

Robotic Stereotactic Radiofrequency Disconnection of Hypothalamic Hamartoma for Drug-Refractory Epilepsy: An Emerging Technique

Raghu Samala1*, Nikit Shah2, Prasanthi Aripirala2

1Department of Neurosurgery, Institute of Neurosciences, AIG Hospitals, Hyderabad, India
2Department of Pediatric Neurology, Rainbow Hospitals, Hyderabad, India

*Corresponding Author: Raghu Samala, Division of Epilepsy and Functional Neurosurgery, Department of Neurosurgery, Institute of Neurosciences, AIG Hospitals, Hyderabad, India.

Received: May 15, 2026; Published: June 30, 2026

Abstract

Hypothalamic hamartomas (HH) are rare, benign developmental malformations frequently associated with drug-refractory epilepsy, particularly gelastic seizures. Hypothalamic hamartomas attached to the hypothalamus, pose unique technical challenges for conventional surgical approaches due to deep-seated location and ill-defined hypothalamic interfaces. Robotic stereotactic radiofrequency (RF) disconnection offers submillimetric precision targeting and real-time intraoperative verification, representing an advanced minimally invasive alternative. We present a 3.5-year-old boy with 1.5 years of pharmacoresistant gelastic and focal seizures in whom MRI demonstrated a type 3B HH attached to the right hypothalamus. Presurgical evaluation including video- electroencephalography and endocrine profiling excluded significant hormone dysfunction except subclinical hypothyroidism. The planned robotic stereotactic RF disconnection utilizes CT-MRI fusion for trajectory planning, AutoGuide robot-assisted probe placement, and intraoperative O-arm CT confirmation, with 13 lesions through 4 trajectories at 74°C for 60 seconds per lesion. This case exemplifies the application of robot-assisted stereotactic RF disconnection for deep-seated, sessile intraventricular HH, balancing high seizure control rates with preservation of hypothalamic function and minimal permanent morbidity.

Keywords: Hypothalamic Hamartoma; Gelastic Seizures; Drug-Refractory Epilepsy; Robotic Stereotactic Radiofrequency Disconnection; Minimally Invasive Neurosurgery

References

  1. Wilfong AA and Curry DJ. “Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis”. Epilepsia 59 (2018): S3-S9.
  2. Delalande O and Fohlen M. “Stereoelectroencephalography and endoscopic surgery for hypothalamic hamartomas”. Neurosurgery Focus2 (2010): E4.
  3. Shirozu H., et al. “Electroclinical features of seizures associated with hypothalamic hamartomas”. Journal of Neurology, Neurosurgery and Psychiatry 4 (2005): 512-518.
  4. Mullatti N., et al. “Pathophysiology of gelastic seizures in hypothalamic hamartoma: a review”. Epilepsy Behavior 97 (2019): 47-55.
  5. Delalande O., et al. “Hypothalamic hamartomas: the stereotactic approach”. Neurosurgery 72(2013): 191-200.
  6. Mullatti N and Selway RP. “Surgical approaches to hypothalamic hamartomas". Child's Nervous System1 (2023): 249-258.
  7. Tandon V., et al. “Stereotactic radiofrequency thermocoagulation of hypothalamic hamartoma with robotic guidance”. World Neurosurgery 116 (2018): e1127-e1133.
  8. Pati S., et al. “Real-time stereotactic laser ablation of hypothalamic hamartomas with robotic guidance”. Neurosurgery2 (2019): E347-E357.
  9. Kameyama S., et al. “Long-term seizure outcomes after stereotactic radiofrequency thermocoagulation for hypothalamic hamartomas”. Epilepsia 11 (2016): 1789-1798.
  10. Reinacher PC., et al. “Long-term outcomes of stereotactic radiofrequency ablation in hypothalamic hamartomas: a single-center experience”. Epilepsia 2 (2025): e1-e12.
  11. Rampp S., et al. “Outcome of surgery for hypothalamic hamartoma-related epilepsy”. Neurology 12 (2024): e209026.
  12. Shirozu H., et al. “Long-term seizure outcomes in patients with hypothalamic hamartoma treated by stereotactic radiofrequency thermocoagulation”. Epilepsia Open4 (2021): 648-658.
  13. Li Y., et al. “Repeat stereotactic radiofrequency thermocoagulation in patients with hypothalamic hamartoma and seizure recurrence”. Epilepsia 1 (2020): 130-138.
  14. Doddamani RS., et al. “Hypothalamic Hamartoma and Endocrinopathy: A Neurosurgeon's Perspective”. Neurology India 68 (2020): S146-S153.
  15. Franzini A., et al. “Lesion-guided stereotactic radiofrequency thermocoagulation for palliative epilepsy surgery”. Stereotactic and Functional Neurosurgery1 (2016): 36-45.
  16. Parrent AG. “Stereotactic radiofrequency ablation for hypothalamic hamartomas”. Epilepsia 45 (2004): 49-54.
  17. Nariai H., et al. “Complications of MR-guided stereotactic laser ablation of hypothalamic hamartomas”. Epilepsia 3 (2021): e64-e72.
  18. Pati S., et al. “Robotic stereotactic laser ablation for hypothalamic hamartomas”. Journal of Neurosurgery: Pediatrics3 (2019): 299-307.
  19. Koutromanou E., et al. “Long-term seizure outcomes in patients with hypothalamic hamartoma-related epilepsy: systematic review and meta-analysis”. Epilepsia2 (2024): 445-458.
  20. Procopio F., et al. “Endoscopic disconnection of hypothalamic hamartomas". Child's Nervous System4 (2022): 629-638.
  21. Ng YT., et al. “Surgical outcomes in children with hypothalamic hamartomas: a comparison of transcallosal and transventricular endoscopic approaches”. Journal of Neurosurgery: Pediatrics6 (2019): 735-745.

Citation

Citation: Raghu Samala., et al. “Robotic Stereotactic Radiofrequency Disconnection of Hypothalamic Hamartoma for Drug-Refractory Epilepsy: An Emerging Technique". Acta Scientific Neurology 9.7 (2026): 06-12.

Copyright

Copyright: ©2026 Raghu Samala., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit manuscripts on/before July 15, 2026, for the upcoming issue of 2026.

Contact US